Serotonin-dopamine interactions in the control of conditioned reinforcement and motor behavior

Neuropsychopharmacology

Volumn 25, Issue 3, 2001, Pages 440-452

  Sasaki Adams, Deanna M ^a   Kelley, Ann E ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Buproprion; Cocaine; Conditioned reinforcement; Dopamine; Fluoxetine; Locomotor activity; Nucleus accumbens; Serotonin

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMFEBUTAMONE; COCAINE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE UPTAKE INHIBITOR; FLUOXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; AROUSAL; ARTICLE; CONDITIONED REFLEX; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; DRUG POTENTIATION; LOCOMOTION; LONG TERM EXPOSURE; MALE; MUSCLE TONE; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REINFORCEMENT; REWARD; SEROTONIN BLOOD LEVEL; STIMULUS RESPONSE; TREATMENT OUTCOME;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; BUPROPION; CONDITIONING, OPERANT; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DRUG INTERACTIONS; FLUOXETINE; MALE; MICROINJECTIONS; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY); SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 0034883022     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(01)00240-8     Document Type: Article

References (77)

1. Bupropion: A review of its mechanism of antidepressant activity
2. Topographical dopamine and serotonin distribution and turnover in rat striatum
3. Facilitation of dopamine release in vivo by serotonin agonists: Studies with microdialysis
4. Activation of a 5-HT3 receptor releases dopamine from rat striatal slice
5. Autoradiographic mapping of 5-HT1B- and 5-HT1D receptors in human brain using [3H]alniditan, a new radioligand
6. Ultrastructural localization of tyrosine hydroxylase in rat nucleus accumbens
7. I. Serotonin (5-HT): Within dopamine reward circuits signals open-field behavior. II. Basis for 5-HT-DA interaction in cocaine dysfunctional behavior
8. Regional distribution of neuropeptide Y Y2 receptor messenger RNA in the human post mortem brain
9. Food restriction enhances the central rewarding effect of abused drugs
10. A search for the metabolic signal that sensitizes lateral hypothalamic self-stimulation in food-restricted rats
11. Potentiation of the effects of reward-related stimuli by dopaminergic-dependent mechanisms in the nucleus accumbens
12. Modulation of the discriminative stimulus properties of cocaine by 5- HT1B and 5-HT2C receptors
13. Modulation of the discriminative stimulus properties of cocaine: Comparison of the effects of fluoxetine with 5-HT1A and 5-HT1B receptor agonists
14. Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release
15. Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens
16. Potentiation of reward-related responding by psychostimulant infusion into nucleus accumbens: Role of dopamine receptor subtypes
17. Effect of acute and chronic fluoxetine on extracellular dopamine levels in the caudate-putamen and nucleus accumbens of rat
18. The role of serotonin in the actions of psychostimulants: Molecular and pharmacological analyses
19. Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat
20. Serotonin enhances striatal dopamine outflow in vivo through dopamine uptake sites
21. Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: Role of 5-HT3 receptors
22. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats
23. 2C receptor messenger RNA in the basal ganglia of adult rats
24. False labelling of dopaminergic terminals in the rabbit caudate nucleus: Uptake and release of [3H]-5-hydroxytryptamine
25. Effects of d-fenfluramine and metergoline on responding for conditioned reward and the response potentiating effect of nucleus accumbens d-amphetamine
26. Injection of 5-HT into the nucleus accumbens reduces the effects of d-amphetamine on responding for conditioned reward
27. Selective destruction of brain serotonin neurons by 5,7-dihydroxytryptamine increases responding for a conditioned reward
28. Effect of chronic antidepressant treatment on transcription factor binding activity in rat hippocampus and frontal cortex
29. 5-HT3 receptor activation is required for induction of striatal c-Fos and phosphorylation of ATF-1 by amphetamine
30. The role of 5-HT3 receptors in drug dependence
31. Interactions between 5-HT3 receptors and cerebral dopamine function: Implications for the treatment of schizophrenia and psychoactive substance abuse
32. Influence of 5-HT1B/1D receptors on dopamine release in the guinea pig nucleus accumbens: A microdialysis study
33. Differential effects of chronic imipramine and fluoxetine on basal and amphetamine-induced extracellular dopamine levels in rat nucleus accumbens
34. 5-HT3 receptors control dopamine release in the nucleus accumbens of freely moving rats
35. Serotonin and motor activity
36. Serotonin-stimulated release of [3H] dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: A comparison with release elicited by potassium, N-methyl-D-aspartic acid, glutamic acid and D-amphetamine
37. Modulation of the potency and efficacy of mumediated antinociception by delta agonists in the mouse
38. Quantitative autoradiography of dopamine D-2 sites in rat caudate-putamen: Localization to intrinsic neurons and not to neocortical afferents
39. Dopamine and conditioned reinforcement. I. Differential effects of amphetamine microinjections into striatal subregions
40. Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding
41. Discriminative stimulus properties of cocaine: Enhancement by monoamine reuptake blockers
42. Feeding and reward interactions from chronic paroxetine treatment
43. Cellular and molecular mechanisms of drug dependence
44. Behavioral aspects of serotonin-dopamine interaction in the monkey
45. Effect of serotonergic agonists in the nucleus accumbens on d-amphetamine-stimulated locomotion
46. The 5-HT3 antagonist zacopride attenuates cocaine-induced increases in extracellular dopamine in rat nucleus accumbens
47. Effects of accumbens m-chlorophenylbiguanide microinjections on sleep and waking in intact and 6-hydroxydopamine-treated rats
48. Characterization of the effects of serotonin on the release of [3H]dopamine from rat nucleus accumbens and striatal slices
49. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis
50. Extracellular serotonin is decreased in the nucleus accumbens during withdrawal from cocaine self-administration
51. Serotonin1b receptor stimulation enhances dopamine-mediated reinforcement
52. Light microscopic immunocytochemical evidence of converging serotonin and dopamine terminals in ventrolateral nucleus accumbens
53. Role of reward and enhancement of conditioned reward in persistence of responding for cocaine
54. Interactions of 5-hydroxytryptamine and gamma-aminobutyric acid with dopamine
55. Dopamine D-1 and D-2 antagonists attenuate amphetamine-produced enhancement of responding for conditioned reward in rats
56. The acquisition of responding with conditioned reinforcement: Effects of pipradrol, methylphenidate, d-amphetamine, and nomifensine
57. Neurobehavioural mechanisms of reward and motivation
58. The putative 5-HT3 agonist phenylbiguanide induces carrier-mediated release of [3H]dopamine
59. Dopamine neurons and their role in reward mechanisms
60. The potentiating effect of sertraline and fluoxetine on amphetamine-induced locomotor activity is not mediated by serotonin
61. 3 receptors mediate fluoxetine but not desipramine-induced increase of extracellular dopamine in the prefrontal cortex
62. Enhanced behavioural control by conditioned reinforcers following microinjections of d-amphetamine into the nucleus accumbens
63. Activating properties of cocaine and cocaethylene in a behavioral preparation of Drosophila melanogaster
64. Time course of brain serotonin metabolism after cessation of long-term fluoxetine treatment in the rat
65. Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to the rat prefrontal cortex and nucleus accumbens
66. Ultrastructure of serotonin-immunoreactive terminals in the core and shell of the rat nucleus accumbens: Cellular substrates for interactions with catecholamine afferents
67. Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders
68. Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine
69. Decreases locomotor activity and attenuation of amphetamine hyperactivity with intraventricular infusion of serotonin in the rat
70. Brain dopamine and reward
71. Endogenous serotonin stimulates striatal dopamine release in conscious rats
72. Serotonergic stimulation of the ventrolateral striatum induces orofacial stereotypy
73. Role of dopamine in behavioral effects of serotonin microinjected into rat striatum
74. Preclinical pharmacology of fluoxetine, a serotonergic drug for weight loss
75. Effect of cocaine and 5-HT3 receptor antagonists on 5-HT-induced [3H]dopamine release from rat striatal synaptosomes
76. Possibility of 5-HT3 receptor involvement in alcohol dependence: A microdialysis study of nucleus accumbens dopamine and serotonin release in rats with chronic alcohol consumption